Related Experiment Video
Updated: Feb 16, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study
Christian Vokuhl1, Nasenien Nourkami-Tutdibi2, Rhoikos Furtwängler2
1Kiel Pediatric Tumor Registry, Department of Pediatric Pathology, Christian-Albrechts-University Kiel, Kiel, Germany.
Background:
Congenital mesoblastic nephroma (MN) is a rare pediatric renal tumor representing approximately 5% of all pediatric renal tumors. Three different types of MN are distinguished histologically: classical, cellular, and mixed. A frequent genetic alteration is the translocation t(12;15) resulting in a fusion of the ETV6 gene on 12p13 and the NTRK3 gene on 15p15 that occurs almost exclusively in cellular MN. The aim of this study was to determine translocation status of a large cohort of MN with respect to tumor subtype and outcome.
Procedure:
In total, clinical data from 111 patients were available. Sixty-seven tumors were classical MN (51%), 29 cellular MN (31%), and 15 were mixed MN (18%). From these 111 cases, 79 were analyzed by FISH and RT-PCR.
Results:
All classical and mixed MN were translocation negative. Seventeen out of 29 (58%) cellular MN harbored the ETV6-NTRK3 translocation. Five-year relapse-free survival (RFS) and overall survival (OS) were 93.2% and 96.8% for the complete cohort. All seven relapses occurred in translocation negative tumors. Five-year RFS was significantly inferior for cellular and mixed MN compared to classic MN (89%, 80%, and 98%), whereas 5-year OS was similar (93%, 96%, and 98%). Within the group of cellular MN, patients having translocation-positive tumors had a significantly superior RFS (5-year RFS: 100% vs. 73%).
Conclusion:
The majority of cellular MNs harbor the ETV6-NTKR3 gene fusion, whereas all classic- and mixed-type MNs were translocation negative. Within the cellular subgroup, patients having translocation-positive tumors had a significantly superior RFS.
Insights
Congenital mesoblastic nephroma (MN) subtype impacts prognosis. Cellular MNs with the ETV6-NTRK3 translocation show superior relapse-free survival compared to translocation-negative tumors.
Area of Science:
- Pediatric Oncology
- Molecular Pathology
- Genetics
Background:
- Congenital mesoblastic nephroma (MN) is a rare pediatric renal tumor.
- Histologically, MN is classified into classical, cellular, and mixed types.
- The ETV6-NTRK3 gene fusion is a frequent alteration in cellular MN.
Purpose of the Study:
- To determine the translocation status in a large cohort of MN.
- To correlate translocation status with MN subtype and patient outcomes.
Main Methods:
- Analysis of clinical data from 111 MN patients.
- Histological classification into classical (51%), cellular (31%), and mixed (18%) types.
- Fluorescence in situ hybridization (FISH) and reverse transcription-polymerase chain reaction (RT-PCR) on 79 tumors.
Main Results:
- All classical and mixed MN were translocation-negative.
- The ETV6-NTRK3 translocation was detected in 58% of cellular MN.
- Translocation-positive cellular MN demonstrated significantly superior 5-year relapse-free survival (100% vs. 73%).
Conclusions:
- The ETV6-NTRK3 fusion is characteristic of cellular MN.
- Translocation status is a key prognostic factor in cellular MN.
- This finding aids in risk stratification and personalized treatment of pediatric MN.
Related Concept Videos
Data Reporting and Recording
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Types of Reports III: Telephone and Verbal Reports
Here's an overview of each type:
Telephone Orders
Reporter Genes
Introduction to Documentation and Reporting
Nursing documentation records essential information and details regarding a patient's care and treatment in written or electronic form. It is a critical aspect of nursing practice that involves documenting assessments, interventions, outcomes, and other relevant details about a patient's health status.
Documentation maps the patient's health journey by creating a comprehensive...

